ProQR Therapeutics BV Earnings

The next earnings date for ProQR Therapeutics BV is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of ProQR Therapeutics BV Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-0.10

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

ProQR Therapeutics BV Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/31/2025	---	$0	100.00%
05/22/2025	Before Market	$-0.11	30.63%
11/07/2024	---	$-0.08	42.92%
08/01/2024	Before Market	$-0.03	76.92%
05/09/2024	Before Market	$-0.09	18.18%
03/13/2024	Before Market	$-0.07	-800.00%
11/07/2023	Before Market	$-0.07	22.22%
08/03/2023	Before Market	$-0.10	9.09%
05/16/2023	Before Market	$-0.11	8.33%
03/29/2023	After Market	$-0.16	0.00%
11/09/2022	Before Market	$-0.34	-61.90%
08/04/2022	Before Market	$-0.21	4.55%
05/05/2022	After Market	$-0.20	16.67%
02/24/2022	Before Market	$-0.26	-36.84%
11/04/2021	Before Market	$-0.22	-4.76%
08/05/2021	Before Market	$-0.24	0.00%
05/06/2021	Before Market	$-0.25	0.00%
02/25/2021	Before Market	$-0.26	-4.00%
11/16/2020	Before Market	$-0.26	13.33%
08/06/2020	After Market	$-0.08	75.00%
05/07/2020	Before Market	$-0.32	5.88%
02/26/2020	Before Market	$-0.39	-11.43%
11/06/2019	Before Market	$-0.31	8.82%
08/07/2019	Before Market	$-0.32	15.79%
05/08/2019	Before Market	$-0.41	0.00%
02/27/2019	Before Market	$-0.38	-46.15%
11/07/2018	Before Market	$-0.21	32.26%
08/08/2018	Before Market	$-0.27	35.71%
05/09/2018	Before Market	$-0.42	6.67%
02/28/2018	Before Market	$-0.46	4.17%
11/20/2017	Before Market	$-0.49	5.77%
08/16/2017	Before Market	$-0.47	9.62%
05/17/2017	Before Market	$-0.48	7.69%
02/28/2017	Before Market	$-0.41	22.64%
11/14/2016	Before Market	$-0.48	11.11%
08/17/2016	Before Market	$-0.49	-2.08%
05/18/2016	Before Market	$-0.49	-19.51%
02/17/2016	Before Market	$-0.28	26.32%
11/23/2015	Before Market	$-0.30	-15.38%
08/19/2015	Before Market	$-0.41	-17.14%
05/21/2015	Before Market	$0.01	103.85%
02/26/2015	Before Market	$-0.34	-21.43%
11/24/2014	Before Market	$-0.57	-21.28%

More About ProQR Therapeutics BV

Website

https://www.proqr.com

Country

USA

Full Time Employees

166

ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products pipeline includes AX-0810 for cholestatic diseases targeting Na-taurocholate cotransporting polypeptide (NTCP); and AX-1412 for cardiovascular diseases (CVDs) targeting Beta-1,4-galactosyltransferase 1 (B4GALT1). It also develops various other early-stage research programs, including AX-1005 for undisclosed targets in CVDs; AX-2402, which focuses on Rett syndrome; AX-2911 for metabolic dysfunction-associated steatohepatitis (MASH) targeting patatin-like phospholipase domain-containing protein 3 (PNPLA3); AX-0601 for obesity and Type 2 diabetes; and AX-9115 for rare metabolic condition, as well as additional programs in Rett Syndrome, additional CNS programs, and multiple other unnamed targets and programs. In addition, the company develops Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center; Inserm Transfert SA; Ionis Pharmaceuticals, Inc.; Vico Therapeutics B.V.; University of Rochester; and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

“ProQR Therapeutics BV Earnings” Can Refer to the ProQR Therapeutics BV Earnings Date

Some people say “ProQR Therapeutics BV earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my ProQR Therapeutics BV position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning ProQR Therapeutics BV Stock on the Earnings Date

If you own ProQR Therapeutics BV stock (PRQR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for ProQR Therapeutics BV might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading ProQR Therapeutics BV shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More ProQR Therapeutics BV Earnings

You can contact us any time if you would like to ask questions about ProQR Therapeutics BV earnings or anything else related to the stock market.